Skip to content
10-Q

Quarterly Report

European Biotech Acquisition Corp.

0001193125-21-196340

← back to feed
Filed
Jun 22, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2021 · Mar 31, 2021 $1.61M
Current Liabilities Q1 2021 · Mar 31, 2021 $819.58K
Total Liabilities Q1 2021 · Mar 31, 2021 $9.59M
Current Assets Q1 2021 · Mar 31, 2021 $1.86M
Total Assets Q1 2021 · Mar 31, 2021 $122.22M